WILLIAM A. GRAY, MD, FACC, FSCAI

System Chief, Division of Cardiovascular Diseases, Main Line Health

President, Lankenau Heart Institute

William A. Gray, MD, is an interventional cardiologist, board certified in internal medicine, cardiology, interventional cardiology, vascular medicine and endovascular medicine.  Dr. Gray serves as System Chief, Division of Cardiovascular Diseases at Main Line Health and President of Lankenau Heart Institute in Wynnewood, PA. 

Dr. Gray has served in cardiovascular leadership roles for nearly 20 years. As Director of Endovascular Services at New York-Presbyterian/ Columbia University Medical Center from 2005-2015, and from 1999 to 2005 as Director of Endovascular Services at Swedish Medical Center in Seattle.  In addition to his leadership positions, Dr. Gray has been instrumental in growing the field of endovascular medicine through clinical training program development and oversight. He started the endovascular fellowship program at Swedish Medical Center in 2002 and served as its director for 3 years. He then launched and for 10 years directed the endovascular fellowship program in the cardiology division of Columbia University College of Physicians and Surgeons, where he was an Associate Professor of Medicine.

During his tenure at New York-Presbyterian/ Columbia University Medical Center, Dr. Gray’s clinical practice encompassed the full range of catheter-based coronary, structural, and vascular diagnostic and therapeutic interventions, including repair of structural heart defects, aneurysm management, and head-to-toe arterial and venous interventions. In addition to directing endovascular services, Dr. Gray ran the mitral valve repair program, was active in the left atrial appendage closure program, and started an interdisciplinary program for management of pulmonary embolism.

Dr. Gray has significant research experience and has served as principal investigator for more than 50 clinical trials of coronary, endovascular, and structural heart interventions. He often is called upon to consult on development of both device and protocol design for national multicenter clinical trials of experimental devices, which has led to his increasing role as national principal investigator. In the past 15 years, Dr. Gray has led several clinical studies leading to FDA approval or clearance for new interventional devices.

Dr. Gray is a Fellow of the American College of Cardiology and a Fellow of The Society for Cardiac Angiography and Interventions. He has served on the editorial board of JACC: Cardiovascular Interventions and is a current editorial board member of Catheterization and Cardiovascular Interventions as well as a reviewer for several other peer-reviewed cardiovascular publications.  

Dr. Gray is board certified in internal medicine, general cardiology, and interventional cardiology and in endovascular medicine and vascular medicine. He earned his medical degree from Temple University School of Medicine in Philadelphia. He completed an internal medicine residency and year as chief resident at Brown University/Rhode Island Hospital followed by a cardiology fellowship and interventional cardiology fellowship at the same medical institution.